| Literature DB >> 32547275 |
Alfredo De Giorgi1, Emanuele Di Simone1, Rosaria Cappadona2, Benedetta Boari1, Caterina Savriè1, Pablo J López-Soto3, María A Rodríguez-Borrego3, Massimo Gallerani1, Roberto Manfredini2, Fabio Fabbian2.
Abstract
PURPOSE: Burden of comorbidities appears to be related to clinical outcomes in hospitalized patients. Clinical stratification of admitted patients could be obtained calculating a comorbidity score, which represents the simplest way to identify the severity of patients' clinical conditions and a practical approach to assess prevalent comorbidities. Our aim was to validate a modified Elixhauser score for predicting in-hospital mortality (IHM) in internal medicine admissions and to compare it with a different one derived from clinical data previously used in a similar setting, having a good prognostic accuracy. PATIENTS AND METHODS: A single-center retrospective study enrolled all patients admitted to internal medicine department between January and June 2016. A modified Elixhauser score was calculated from chart review and administrative data; moreover, a second prognostic index was calculated from chart review only. Comorbidity scores were compared using c-statistic.Entities:
Keywords: comorbidity score; in-hospital mortality; internal medicine wards; validation
Year: 2020 PMID: 32547275 PMCID: PMC7246324 DOI: 10.2147/RMHP.S247633
Source DB: PubMed Journal: Risk Manag Healthc Policy ISSN: 1179-1594
Main Characteristics of the 1,614 Individuals Investigated
| Age (years) | 79.1±13.1 |
| Male/female (n(%)) | 699 (43.3)/915 (56.7) |
| In-hospital death (n(%)) | 224 (13.9) |
| Serum creatinine>3 mg/dl (n(%)) | 126 (7.8) |
| Independency in activities of daily living | 2.64±2.58 |
| Albumin (g/dl) | 3.1±0.6 |
| Modified Elixhauser score calculated from electronic medical charts | 24.43±11.27 |
| Modified Elixhauser score calculated from administrative data recorded at the time of discharge | 18.13±9.36 |
| Prognostic index derived from clinical data from Cei et al | 7.63±3.3 |
Comparison of Prevalence of the Different Conditions Considered in Order to Calculate the Different Scores Using Both Electronic Medical Charts and Administrative Data Recorded at the Time of Discharge
| Comorbidities Derived From Electronic Medical Charts | Comorbidities Derived From Administrative Data Recorded at the Time of Discharge | |
|---|---|---|
| Congestive heart failure (n(%)) | 292 (18.1) | 292 (18.1) |
| Ischemic heart disease (n(%)) | 395 (24.5) | 57 (3.5) |
| Solid tumor without metastasis (n(%)) | 502 (31.1) | 98 (6.1) |
| Metastasis (n(%)) | 88 (5.5) | 80 (5) |
| Renal diseases (n%) | 456 (28.3) | 348 (21.6) |
| Neurological disorders (n(%)) | 438 (27.1) | 55 (3.4) |
| Coagulopathy (n(%)) | 546 (33.8) | 276 (17.1) |
| Weight loss (n(%)) | 627 (38.8) | 519 (32.2) |
| Fluid and electrolyte disorders (n%) | 237 (14.7) | 120 (7.4) |
| Liver disease (n(%)) | 206(12.8) | 30 (1.9) |
Main Characteristics of Deceased and Survivors
| Deceased | Survivors | P | |
|---|---|---|---|
| Age (years) | 83.3±9.1 | 78.4±13.5 | <0.001 |
| Male/Female (n(%)) | 88 (39.3)/136 (60.7) | 611 (44)/779 (56) | ns |
| Serum creatinine >3 mg/dl (n(%)) | 30 (13.4) | 96 (6.9) | 0.001 |
| Independency in activities of daily living | 0.83±1.79 | 2.93±2.57 | <0.001 |
| Albumin (g/dl) | 2.8±0.6 | 3.2±0.5 | <0.001 |
| Modified Elixhauser score calculated from electronic medical charts | 35.43±9.79 | 22.66±10.43 | <0.001 |
| Modified Elixhauser score calculated from administrative data recorded at the time of discharge | 24.31±7.98 | 17.13±9.19 | <0.001 |
| Prognostic index derived from clinical data from Cei et al | 10.04±3.67 | 7.24±3.07 | <0.001 |
Comparison of Prevalence of the Different Conditions Considered in Order to Calculate the Different Scores Using Electronic Medical Charts and Administrative Data Recorded at the Time of Discharge in Deceased and Survivors
| Conditions Evaluated Using Electronic | Conditions Evaluated Using Administrative Data | |||||
|---|---|---|---|---|---|---|
| Deceased | Survivors | p | Deceased | Survivors | p | |
| Congestive heart failure (n(%)) | 81 (36.2) | 211 (15.2) | <0.001 | 57 (25.4) | 235 (16.9) | 0.002 |
| Ischemic heart disease (n(%)) | 51 (22.8) | 344 (24.7) | ns | 6 (2.7) | 51 (3.7) | ns |
| Solid tumor without metastasis (n(%)) | 93 (41.5) | 409 (29.4) | <0.001 | 18 (8) | 80 (5.8) | ns |
| Metastasis (n(%)) | 29 (12.9) | 59 (4.2) | <0.001 | 24 (10.7) | 56 (4) | <0.001 |
| Renal diseases (n%) | 88 (39.3) | 368 (26.5) | <0.001 | 41 (18.3) | 307 (22.1) | ns |
| Neurological disorders (n(%)) | 76 (33.9) | 362 (26) | 0.014 | 10 (4.5) | 45 (3.2) | ns |
| Coagulopathy (n(%)) | 111 (49.6) | 435 (31.3) | <0.001 | 39 (17.4) | 237 (17.1) | ns |
| Weight loss (n(%)) | 175 (78.1) | 425 (32.5) | <0.001 | 159 (71) | 360 (25.9) | <0.001 |
| Fluid and electrolyte disorders (n%) | 76 (33.9) | 161 (11.6) | <0.001 | 18 (8) | 102 (7.3) | ns |
| Liver disease (n(%)) | 32 (14.3) | 174 (12.5) | ns | 2 (0.9) | 28 (2) | ns |
Figure 1Receiver operating characteristics (ROC) analysis reporting the area under the receiver-operator characteristic curve of the different scores evaluated.
Figure 2Relationship between values of modified Elixhauser score calculated by administrative data and risk of in-hospital mortality (IHM).